Fundz

Sensorium Therapeutics

BOSTON, Massachusetts, United States · Healthcare, Health Care

Sensorium embraces the biological complexity of the human brain and nature to develop breakthrough medicines to address a growing unmet medical need in mental health and neurological diseases.

Key facts

Headquarters
BOSTON, Massachusetts, United States
Employees
27
Industries
Healthcare, Health Care
Status
Private
Website
www.sensorium.bio
LinkedIn
Company page

Recent activity at Sensorium Therapeutics

Sensorium Therapeutics funding history

DateRoundAmount
Feb 2025Venture$14.5M
Nov 2022Series A$30.0M
Oct 2022Venture$15.5M
Jul 2021Venture$26.8M

Leadership

  • Richard Simon, Executive Officer, Director
  • Jerrold Rosenbaum, Director
  • Cole Brown, M.D., Chief Medical Officer
  • Jacob Hooker, President
  • Sam Rasty, Chief Business Officer
  • Dick Simon, Founder
  • Pranav Tadi, Executive Officer

Verified email and direct lines for Sensorium Therapeutics’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.

Employee benefit plans

Sensorium Therapeutics files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.

Sensorium Therapeutics in the news

Companies similar to Sensorium Therapeutics

About Sensorium Therapeutics: questions and answers

What does Sensorium Therapeutics do?

Sensorium embraces the biological complexity of the human brain and nature to develop breakthrough medicines to address a growing unmet medical need in mental health and neurological diseases.

Where is Sensorium Therapeutics headquartered?

Sensorium Therapeutics is headquartered in BOSTON, Massachusetts, United States.

How many employees does Sensorium Therapeutics have?

Sensorium Therapeutics has about 27 employees.

Has Sensorium Therapeutics raised funding?

Yes. Fundz has recorded 4 funding events for Sensorium Therapeutics. The most recent, $14.5M, was in Feb 2025.

Who leads Sensorium Therapeutics?

Jacob Hooker is a President at Sensorium Therapeutics.

What is the latest news on Sensorium Therapeutics?

On May 27, 2026, Sensorium Therapeutics Appoints Cole Brown, M.D. as Chief Medical Officer

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches Sensorium Therapeutics across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.